Medical Imaging

RIVANNA®, developers of imaging-based medical technologies, announced that it received $9.92 million in federal funding of a contractual option from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). With the execution, this option funding will support the…

AI heart failure diagnostics innovator makes it possible to catch deadly heart failure earlier by analyzing the most common heart scan in the world and proactively alerting clinicians FDA-cleared, reimbursed by Medicare, and live in top U.S. hospitals, Ultromics is now scaling nationwide to make early heart failure detection part of routine cardiac care, wherever…

Computed Echo Tomography (CET) Described as Addressing Limitations of Conventional Ultrasound MAUI Imaging, inventor of patented technology that visualizes anatomy often missed with conventional ultrasound, today highlighted publication of a baseline B-mode imaging analysis for traumatic injuries in the peer-reviewed Journal of The American College of Emergency Physicians (JACEP Open) https://www.jacepopen.com/article/S2688-1152%2825%2900139-0/fulltext. “The authors found Computed Echo Tomography-based…

Qynapse, a technology company using AI to enhance the quantification and predictive capabilities of imaging to improve outcomes for neurological diseases, including Alzheimer’s disease (AD), presented new data at the Alzheimer’s Association International Conference (AAIC) for QyScore® and QyPredict®. QyScore® is an FDA-cleared and CE-marked proprietary neuroimaging software platform that enables fully automated, high-resolution segmentation of brain structures…

Tigermed (300347.SZ / 3347.HK), a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, today announces the completion of its acquisition of CRO company Micron,Inc. Founded in 2005 and headquartered in Tokyo, Micron is a Japan-based Contract Research Organization (CRO) focusing in medical imaging and clinical trial services…

This partnership significantly increases global access to XenoSTART’s high-demand tumor models. Scientist.com, the leading R&D procurement orchestration platform for the life sciences, today announced a major expansion of its Tumor Model Finder (TMF) following a strategic partnership with XenoSTART, a global leader in patient-derived xenograft (PDX) model development and testing. The addition of hundreds of…

Compound to be evaluated as a potentially best-in-class treatment for rare genetic forms of obesity and hypothalamic obesity, as well as part of the treatment regimen for adult obesity patients In preclinical studies, the molecule demonstrated high selectivity, a broad therapeutic window, and a favorable safety profile compared to existing treatments and those in development…

AIRS Medical, creator of the AI-powered MRI enhancement solution SwiftMR, is expanding its global footprint through strategic partnerships and a surge in customer growth across Latin America. In the past six months alone, more than 150 imaging centers in Brazil have adopted SwiftMR, underscoring the region’s increasing demand for faster, AI-enhanced MRI. Scaling SwiftMR in Latin America In 2024, AIRS…